|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:dateCreated |
2011-3-16
|
|
pubmed:databankReference |
|
|
pubmed:abstractText |
Several studies have shown an association of cryptogenic stroke and embolism with patent foramen ovale (PFO), but the question how to prevent further events in such patients is unresolved. Options include antithrombotic treatment with warfarin or antiplatelet agents or surgical or endovascular closure of the PFO. The PC-Trial was set up to compare endovascular closure and best medical treatment for prevention of recurrent events.
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/21356042-11071496,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21356042-1451261,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21356042-14597460,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21356042-1503349,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21356042-15078999,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21356042-1510018,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21356042-15312853,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21356042-1585866,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21356042-16432246,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21356042-1801769,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21356042-1918693,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21356042-2502956,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21356042-2898621,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21356042-3362165,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21356042-6337424,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21356042-6847145,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21356042-7484740,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21356042-7771841,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21356042-7875067,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21356042-7924938,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21356042-7942465,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21356042-8124830,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21356042-8231212,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21356042-8248969,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21356042-8291943,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21356042-8403322,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21356042-8579033,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21356042-8628471,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21356042-8681757,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21356042-9033708,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21356042-9175227,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21356042-9476306
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1745-6215
|
|
pubmed:author |
pubmed-author:AndersenHenning RHR,
pubmed-author:DudekDariuszD,
pubmed-author:Hildick-SmithDavidD,
pubmed-author:IbrahimRedaR,
pubmed-author:KhattabAhmed AAA,
pubmed-author:MattleHeinrich PHP,
pubmed-author:MeierBernhardB,
pubmed-author:ReyesL ILI,
pubmed-author:SchulerGerhardG,
pubmed-author:WahlAndreasA,
pubmed-author:WaltonAntony SAS,
pubmed-author:WindeckerStephanS
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
12
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
56
|
|
pubmed:dateRevised |
2011-7-26
|
|
pubmed:meshHeading |
pubmed-meshheading:21356042-Adult,
pubmed-meshheading:21356042-Anticoagulants,
pubmed-meshheading:21356042-Australia,
pubmed-meshheading:21356042-Canada,
pubmed-meshheading:21356042-Embolism, Paradoxical,
pubmed-meshheading:21356042-Europe,
pubmed-meshheading:21356042-Foramen Ovale, Patent,
pubmed-meshheading:21356042-Heart Catheterization,
pubmed-meshheading:21356042-Humans,
pubmed-meshheading:21356042-Middle Aged,
pubmed-meshheading:21356042-Platelet Aggregation Inhibitors,
pubmed-meshheading:21356042-Prospective Studies,
pubmed-meshheading:21356042-Prosthesis Design,
pubmed-meshheading:21356042-Recurrence,
pubmed-meshheading:21356042-Research Design,
pubmed-meshheading:21356042-Septal Occluder Device,
pubmed-meshheading:21356042-Stroke,
pubmed-meshheading:21356042-Time Factors,
pubmed-meshheading:21356042-Treatment Outcome
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Randomized clinical trial comparing percutaneous closure of patent foramen ovale (PFO) using the Amplatzer PFO Occluder with medical treatment in patients with cryptogenic embolism (PC-Trial): rationale and design.
|
|
pubmed:affiliation |
Cardiology Department, Bern University Hospital, Bern, Switzerland.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
